Guangdong Biolight Meditech Co., Ltd. (SHE:300246)
China flag China · Delayed Price · Currency is CNY
7.20
+0.23 (3.30%)
Apr 30, 2025, 2:45 PM CST

SHE:300246 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Market Capitalization
1,8231,7242,7252,8693,1923,795
Upgrade
Market Cap Growth
-9.77%-36.74%-5.01%-10.13%-15.90%67.83%
Upgrade
Enterprise Value
1,8652,0112,9062,6023,2463,552
Upgrade
Last Close Price
6.976.5910.3010.7514.2216.56
Upgrade
PE Ratio
---129.6250.0410.97
Upgrade
Forward PE
-51.9551.9551.9551.9551.95
Upgrade
PS Ratio
1.751.632.282.422.932.72
Upgrade
PB Ratio
1.391.341.961.913.223.68
Upgrade
P/TBV Ratio
1.641.582.332.404.725.49
Upgrade
P/FCF Ratio
-----9.80
Upgrade
P/OCF Ratio
--21.1220.3939.608.33
Upgrade
EV/Sales Ratio
1.791.902.432.202.982.54
Upgrade
EV/EBITDA Ratio
44.8567.2433.5569.0629.867.97
Upgrade
EV/EBIT Ratio
--77.76-44.718.30
Upgrade
EV/FCF Ratio
-18.42----9.17
Upgrade
Debt / Equity Ratio
0.460.500.420.280.360.26
Upgrade
Debt / EBITDA Ratio
14.3519.896.209.593.150.60
Upgrade
Debt / FCF Ratio
-----0.69
Upgrade
Asset Turnover
0.420.420.480.570.661.09
Upgrade
Inventory Turnover
3.423.423.864.214.306.47
Upgrade
Quick Ratio
1.721.131.441.831.201.75
Upgrade
Current Ratio
2.281.971.782.211.672.20
Upgrade
Return on Equity (ROE)
-4.24%-5.23%-4.22%1.97%6.64%43.53%
Upgrade
Return on Assets (ROA)
-0.61%-0.76%0.94%-0.20%2.73%20.82%
Upgrade
Return on Capital (ROIC)
-0.76%-0.97%1.20%-0.25%3.43%25.83%
Upgrade
Return on Capital Employed (ROCE)
--2.10%-5.90%35.30%
Upgrade
Earnings Yield
-3.32%-4.14%-2.39%0.77%2.00%9.12%
Upgrade
FCF Yield
-5.55%-6.52%-3.35%-2.48%-2.59%10.21%
Upgrade
Dividend Yield
---1.24%0.94%1.61%
Upgrade
Payout Ratio
---184.49%91.47%9.58%
Upgrade
Buyback Yield / Dilution
0.62%0.51%-1.23%-18.96%0.26%-0.26%
Upgrade
Total Shareholder Return
0.62%0.51%-1.23%-17.72%1.19%1.35%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.